AlphAIAlphAI — Financial news for AI agents
prnewswire.comOCT 11 min read$AB

AB to Report Third Quarter 2026 Results on October 27, 2026

AllianceBernstein (NYSE: AB) will release its Q3 2026 results on October 27, 2026, before market open. A conference call is scheduled for 9:00 a.m. CT. As of June 30, 2026, Equitable Holdings owns 68.1% of AB.

Original reporting
prnewswire.com
Published Oct 1, 2026, 4:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 4:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$AB
Neutral
medium confidence
Mentioned
$AB
Relevance
4/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$ABNeutralLow
01

Why it matters

The announcement itself does not provide new financial data, so its immediate trading impact is limited to positioning ahead of the earnings release.

02

Market read

A routine earnings release schedule with minimal immediate market impact.

03

What to watch

Potential hidden guidance or surprise in the upcoming earnings could change the outlook dramatically.

Relevance 4/10Novelty 3/10Timing: pre‑market on Oct 27, 2026

Background

AllianceBernstein (NYSE:AB) is a global investment management firm. The press release informs investors of the upcoming Q3 2026 earnings release date and conference call details.

Company-level read

Ticker impact

$ABNeutralMedium confidence
Context

AllianceBernstein announced the date and time for its Q3 2026 earnings release and conference call.

Expected impact

likely modest pressure or support as traders position ahead of the results, no directional bias without numbers.

Evidence & confidence

No financial figures are disclosed; the news is purely a schedule notice, so any price move will depend on the actual earnings when released.

Market effects

Sector

None beyond the asset‑management sector awaiting the earnings data.

Regional

Limited to U.S. investors tracking the firm.

Global

Low; the announcement is a routine earnings schedule.

Counterpoint

What could challenge this read

If the market over‑reacts to the schedule, a short position could profit if results disappoint.

Key entities

  • Company
    AllianceBernstein L.P.

    Issuer of the earnings release announcement.

Read at source← All news

Related articles

SEP 25
$ABMed

People moves: AllianceBernstein names Onur Erzan as next CEO

AllianceBernstein (AB) named Onur Erzan as its next CEO, effective April 1, 2027. Erzan, currently president, succeeds Seth Bernstein, who retires but remains on AB's board. AB's assets under management are $919 billion, with $169 billion in private wealth. Erzan joined AB in 2021 from McKinsey and has led key initiatives. AB is a subsidiary of Equitable Holdings.

investmentnews.com2 min
AUG 11
$ABMedAI 8/10

AB Science raises EUR 14.2m to fund masitinib Phase III, AB8939

AB Science (Euronext Paris: AB) raised EUR 14.2m via a private placement to fund early steps of a strategic plan due in September. The issue created 23.28m new shares; an existing long-term investor provided EUR 12m. Proceeds target AB8939 in AML and masitinib Phase III in ALS. Cash is about EUR 23m, covering needs beyond 12 months.

allsci.com4 min
JUL 30
$ABMed

AllianceBernstein Holding L.P. Q2 2026 Earnings Call Summary

Strategic Execution and Platform Scaling Achieved record AUM of $905 billion, driven by a return to positive organic growth and the strongest gross sales quarter in five years. Reached the $90 billion to $100 billion private markets AUM target more than a year ahead of schedule, validating a multi-year investment strategy in corporate lending and real estate debt.

yahoo.com6 min
JUL 28
$ABMed

AllianceBernstein Holding LP (AB) Q2 2026 Earnings Call Highlights: Record AUM

AllianceBernstein (AB) discussed Q2 2026 earnings call topics, including expectations for the Equitable Corebridge merger to add about $100B of AUM over a couple of years, with combined general account assets around $350B and separate around $200B. Management cited resilient private wealth adviser productivity, reduced expense guidance by $5-10M, and demand shifts in U.S. taxable fixed income.

yahoo.com6 min
JUL 28
$ABMedAI 8/10

Advanced Bionics Receives FDA Approval for Expanded Cochlear Implant Candidacy Criteria in SSD and AHL

Advanced Bionics, a Sonova brand, said the US FDA approved expanded indications for its cochlear implant systems for single-sided deafness (SSD) and asymmetric hearing loss (AHL). The criteria broaden adult and pediatric eligibility, with company-cited research estimating 271,000 to 345,000 US adults with SSD and only 2.1% using CIs among eligible patients.

hearingreview.com3 min
JUL 28
$ABMed

ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES SECOND QUARTER RESULTS

ALLIANCEBERNSTEIN HOLDING L.P. (AB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.01 2 a2q26earningsrelease.htm EX-99.01 2Q26 RELEASE Document Ioanis Jorgali, Investors 629.213.6139 ioanis.jorgali@alliancebernstein.com Carly Symington, Media 629.213.5568 carly.symington@alliancebernstein.com ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES SECOND QUARTER RESULTS

SEC EDGAR 8-K7 min